Change in the crystalline structure during the phase transition of the palladium-hydrogen system.

We performed an X-ray diffraction experiment while a palladium bulk absorbed and desorbed hydrogen to investigate the behavior of the crystalline lattice during the phase transition between the α phase and the ß phase. Fast growth of the ß phase was observed at around x = 0.1 and x = 0.45 of PdHx, and the phase transition rate has an exponential behavior in between. In addition, slight compression of the lattice at a high hydrogen concentration, an increase in the lattice constant, and broadening of the line width of the α phase after a cycle of absorption and desorption of hydrogen were observed. These behaviors correlated with the change in the sample length, which may infer that the change in shape was related to the phase transition.

Dual-phase Au-Pt alloys free from magnetic susceptibility artifacts in magnetic resonance imaging.

PURPOSE: Magnetic resonance imaging (MRI) devices are frequently used in image-based diagnosis. In the case of large artifacts, which are generated in magnetic resonance (MR) images when magnetic materials, such as metals, are present in the body, these devices are less useful. This study aimed to develop a dual-phase Au-Pt alloy that does not generate artifacts in MR images and has high workability to prepare medical devices. MATERIALS AND METHODS: A processing method to produce a dual-phase Au-Pt alloy was established, and the magnetic susceptibility and artifacts of different alloy compositions were determined using a SQUID (superconducting quantum interference device) flux meter and a 1.5 T-MRI system. The crystallographic phases of the prepared alloy samples were identified using X-ray diffraction. Sample cross-sections were observed using a metallurgical microscope. Furthermore, a thinning test was conducted to examine alloy workability. RESULTS: Dual-phase Au-Pt alloys Au70Pt30 and Au67Pt33-the former heat-treated at 800 and 850 °C and the latter heat-treated at 900 °C-generated minimal artifacts when imaged in a 1.5 T-MRI system. Their volume magnetic susceptibility increased as the heat-treatment temperature decreased. The alloy surfaces were observed to be uniform. Moreover, the workability of the dual-phase alloy was considerably better than that of the single-phase alloy. CONCLUSION: Volume magnetic susceptibility could be controlled by changing the composition and processing temperature of the Au-Pt alloys. Dual-phase Au-Pt alloys those do not generate magnetic susceptibility artifacts in MRI images and have good workability could be prepared. The alloys are expected to be used in the preparation of various implantable medical devices.

Preparation of an Au-Pt alloy free from artifacts in magnetic resonance imaging.

PURPOSE: When magnetic resonance imaging (MRI) is performed on patients carrying metallic implants, artifacts can disturb the images around the implants, often making it difficult to interpret them appropriately. However, metallic materials are and will be indispensable as raw materials for medical devices because of their electric conductivity, visibility under X-ray fluoroscopy, and other favorable features. What is now desired is to develop a metallic material which causes no artifacts during MRI. MATERIALS AND METHODS: In the present study, we prepared a single-phase and homogeneous Au-Pt alloys (Au; diamagnetic metal, and Pt; paramagnetic metal) by the processing of thermal treatment. Volume magnetic susceptibility was measured with a SQUID Flux Meter and MRI artifact was evaluated using a 1.5-T scanner. RESULTS: After final thermal treatment, an entirely recrystallized homogeneous organization was noted. The Au-35Pt alloy was shown to have a volume magnetic susceptibility of -8.8ppm, causing almost free from artifacts during MRI. CONCLUSIONS: We thus prepared an Au-35Pt alloy which had a magnetic susceptibility very close to that of living tissue and caused much fewer artifacts during MRI. It is promising as a material for spinal cages, intracranial electrodes, cerebral aneurysm embolization coils, markers for MRI and so on.